See below for a list of our latest prescribing data reports, evidence reviews, and other publications. If you’re looking for something in particular, please use the search function or get in touch at nuth.nyrdtc.rxsupp@nhs.net.

For a summary of work in progress, see our forthcoming publications.

New and recent publications
Regional prescribing position; North West region.
Top 50 BNF sections and drugs
Cost Comparison Charts
Monthly Financial Headlines
Monthly Horizon Scanning Report – July 2025
Monthly formulary amendments – June 2025
Antibiotic STAR-PU: Updated weightings for 2024 population
Regional Prescribing Position North East and Yorkshire Region.
Price Concessionary Bulletin
Formulary assessment – Spironolactone (Qaialdo) 10 mg/1 ml oral suspension
Sodium Valproate – MO opportunities
Antidepressants – MO opportunities
Blood Glucose Test Strips – MO opportunities
Formulary assessment – Pregabalin prolonged-release tablets
Comparison of DOACs for Atrial Fibrillation
Monthly Horizon Scanning Report – June 2025
Monthly formulary amendments – May 2025
Polypharmacy – MO opportunities
Opioids – MO opportunities
Low priority prescribing – MO opportunities
Antibacterial drugs
Cardiovascular System
Monthly Horizon Scanning Report – May 2025
Medicines value tracker – Shower and Bath emollients; opportunity savings realised
Budget impact of emollient bath and shower preparations
Respiratory System
Drugs for Dementia
Drug Tariff Monitor
NHS Medicines Optimisation Opportunities Dashboard
Drugs used in Diabetes
Cardiovascular – MO opportunities
Medicines value tracker – Metformin 1g tablets; opportunity savings realised
Inhaler Carbon Impact Assessment Tool
Medicines Value Calculators
Monthly formulary amendments – April 2025
Monthly Horizon Scanning Report – April 2025
Inhaler Carbon Footprint – MO opportunities
Formulary assessment – Ciclosporin 0.9 mg/ml eye drops (Cequa)
Oral Vitamin B12 supplementation for vitamin B12 deficiency
Monthly formulary amendments – March 2025
Formulary assessment – Flecainide Acetate 25mg/5mL Oral Solution (Colonis)
Antibacterial – MO opportunities
Oral Sucralfate use in primary care
Monthly Horizon Scanning Report – March 2025
Monthly formulary amendments – February 2025
Pain Management
Monthly Horizon Scanning Report – February 2025
Formulary assessment – Budesonide 9mg MR tablets (Cortiment)
RDTC Annual Horizon Scanning Report 2025-2026
Monthly Horizon Scanning Report – January 2025
Monthly formulary amendments – December 2024
Monthly Horizon Scanning Report – December 2024
Formulary assessment – Ibuprofen 200 mg/50 ml solution for infusion
Monthly formulary amendments – November 2024
ASTRO-PU: Updated weightings for 2024 population
Comparison of levonorgestrel-containing intrauterine devices 
Monthly Horizon Scanning Report – November 2024
Monthly formulary amendments – October 2024
Prescribing Update Newsletter – October 2024
Monthly Horizon Scanning Report – October 2024
Prescribing Update Newsletter – September 2024
Monthly formulary amendments – September 2024
Safer Medication Use – Propranolol in the treatment of anxiety
Disease-modifying therapies for Alzheimer’s disease
Monthly formulary amendments – August 2024
Monthly Horizon Scanning Report – September 2024
Prescribing Update Newsletter – August 2024
Monthly Horizon Scanning Report – August 2024
Monthly formulary amendments – July 2024
Formulary assessment – Melatonin (Adaflex) for ADHD
Formulary assessment – Drospirenone 4mg tablets (Slynd)
Prescribing Update Newsletter – July 2024
Monthly formulary amendments – June 2024
Monthly Horizon Scanning Report – July 2024
Formulary assessment – Hydrocortisone sodium phosphate 5mg/5ml, 10mg/5ml oral solutions
Prescribing Update Newsletter – June 2024
Budget impact of metformin 1g immediate release tablet prescribing
Monthly Horizon Scanning Report – June 2024
Shared care protocol – methylphenidate in adults
Monthly formulary amendments – May 2024
Resource demo sessions
Prescribing Update Newsletter – May 2024
Incorporating primary and secondary care prescribing data to better understand the ICS
Antimicrobial prescribing across primary and secondary care
Shared care protocol – dexamfetamine in adults
Shared care protocol – lisdexamfetamine in adults
Formulary assessment – Calcifediol soft capsules
Formulary assessment – Methylphenidate 2mg/ml oral solution
Monthly Horizon Scanning Report – May 2024
Shared care protocol – atomoxetine in adults
Shared care protocol – guanfacine in children and adults
Shared care protocol – hydroxycarbamide in adults
Formulary assessment – Fezolinetant (Veoza)
Fezolinetant for treating vasomotor symptoms associated with the menopause
Monthly formulary amendments – April 2024
Prescribing Update Newsletter – April 2024
Social Prescribing: Evidence and Outcomes
Monthly Horizon Scanning Report – April 2024
Shared care protocol – leflunomide in adults
Shared care protocol – methotrexate in adults (excluding cancer)
Teriparatide for treatment of osteoporosis in men aged over 50 years
Optimised prescribing of oral iron supplements for iron deficiency anaemia
Prescribing Update Newsletter – March 2024
Monthly formulary amendments – March 2024
Formulary assessment – Levomepromazine (Levorol) 6.25mg tablets
Shared care protocol – lithium in adults
Annual Horizon Scanning Report – 2024-2025 (updated March 2024)
Monthly Horizon Scanning Report – March 2024
Shared care protocol – sulfasalazine in adults
Shared care protocol – mycophenolate mofetil & mycophenolic acid in adults (non-transplant)
Shared care protocol – azathioprine and mercaptopurine for adults
Prescribing Update Newsletter – February 2024
Monthly formulary amendments – February 2024
Formulary assessment – Melatonin (Ceyesto) 1mg/ml oral solution
Monthly Horizon Scanning Report – February 2024
Shared care protocol – ciclosporin (oral) for adults (non-transplant)
Monthly Horizon Scanning Report – January 2024
Shared care protocol – hydroxychloroquine for adults
Shared care protocol – riluzole for adults
Shared care protocol – amiodarone for adults
Shared care protocol – dronedarone for adults
Defining the type-2 diabetic population: a first step to understanding the impact of pathway choices
Budget impact of paracetamol 250mg/5ml oral suspension
Sustainability: Environmental impact of inhaler disposal
Budget impact of acetylcysteine vs carbocisteine
Budget impact of promethazine prescribing